A phase 1/2 study of lentiviral-mediated ex-vivo gene therapy for pediatric patients with severe leukocyte adhesion deficiency-i (LAD-I): Interim results

This article has no abstract
Epistemonikos ID: a514a8b930df2debba010cbc606597471095b216
First added on: Feb 13, 2025